Login to Your Account

NewCo News

Oculus Spinout Ruthigen Focusing on Infection Drug

By Catherine Shaffer
Staff Writer

Tuesday, January 15, 2013
Oculus Innovative Sciences Inc., of Petaluma, Calif., spun out a new biotechnology business to develop a drug candidate for infection in trauma and surgical procedures.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription